ArticleScience translational medicine2024
Abstract read
In one paragraph
Article in Science translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Genetic background of Richter transformation of atypical chronic lymphocytic leukemia to diffuse large B-cell lymphoma - a case study.Journal of applied genetics · 2026Article
- CCL19bioRxiv : the preprint server for biology · 2026Article
- Molecular Pathogenesis and Targeted Treatment of Richter Transformation.Biomedicines · 2026Review
- State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.Blood cancer journal · 2025Article
- Serendipitous and Systematic Chemoproteomic Discovery of MBLAC2, HINT1, and NME1-4 Inhibitors from Histone Deacetylase-Targeting Pharmacophores.ACS chemical biology · 2025Article
- Molecular Features Accompanying Richter's Transformation in Patients with Chronic Lymphocytic Leukemia.International journal of molecular sciences · 2025Review
- Complementary approaches define the metabolic features that accompany Richter syndrome transformation.Cellular and molecular life sciences : CMLS · 2025Article
- A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter Transformation.Frontiers in immunology · 2025Review
- Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing.Frontiers in immunology · 2024Review
Corrections and comments
- Update of
Authors and funding
19 authors.
Prajish IyerDepartment of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, CA 91016, USA.ORCID 0000-0001-6982-6343
Bo ZhangDepartment of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, CA 91016, USA.
Tingting LiuDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0002-1695-8649
Meiling JinDepartment of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, CA 91016, USA.ORCID 0000-0001-8539-9177
Kevyn HartDepartment of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, CA 91016, USA.ORCID 0000-0002-7567-1744
Jibin ZhangDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0003-3099-6665
Viola SiegertInstitute of Clinical Chemistry and Pathobiochemistry, TUM School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.
Marianne RemkeInstitute of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.ORCID 0000-0002-1363-4737
Xuesong WangDepartment of Botany and Plant Sciences, University of California, Riverside, CA 92507, USA.
Lei YuDepartment of Botany and Plant Sciences, University of California, Riverside, CA 92507, USA.ORCID 0000-0001-7817-5319
Joo SongDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0003-3497-2513
Girish VenkataramanDepartment of Pathology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-8674-2608
Wing C ChanDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Zhenyu JiaDepartment of Botany and Plant Sciences, University of California, Riverside, CA 92507, USA.ORCID 0000-0002-1428-904X
Maike BuchnerInstitute of Clinical Chemistry and Pathobiochemistry, TUM School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.
Tanya SiddiqiDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Steven T RosenDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Alexey DanilovDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0003-4461-0970
Lili WangDepartment of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, CA 91016, USA.ORCID 0000-0001-5028-2868
Funding
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemiaR01CA216273 · NCI · DANA-FARBER CANCER INST · PI WANG, LILI, WU, CATHERINE JU-YING · 2017 to 2021
$3.5MDefine the oncogenic role of METTL3 in the pathogenesis of chronic lymphocytic leukemiaR01CA282450 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Lili Wang · 2023 to 2026
$2.3MOvercoming ibrutinib resistance in mantle cell lymphomaR01CA244576 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI DANILOV, ALEXEY V. · 2021 to 2025
$2.2MCooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemiaR01CA240910 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WANG, LILI · 2020 to 2024
$2.1MNCI NIH HHS P30 CA033572NCI NIH HHS R01 CA216273NCI NIH HHS R01 CA240910NCI NIH HHS R01 CA244576NCI NIH HHS R01 CA282450
Abstract
Richter's transformation (RT) is a progression of chronic lymphocytic leukemia (CLL) to aggressive lymphoma.
Indexed as
Leukemia, Lymphocytic, Chronic, B-CellMitochondriaOxidative PhosphorylationAnimalsCell Transformation, NeoplasticDisease Models, AnimalGene DeletionHumansMiceProto-Oncogene Proteins c-mycProto-Oncogene Proteins c-myc
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.